StrolloPJJr, RogersRM. Obstructive sleep apnea. N Engl J Med1996;334(2):99–104.
2.
LamphereJ, RoehrsT, WittigR, ZorickF, ConwayWA, RothT.Recovery of alertness after CPAP in apnea. Chest1989;96(6):1364–1367.
3.
SandersMH, GruendlCA, RogersRM. Patient compliance with nasal CPAP therapy for sleep apnea. Chest1986;90(3):330–333.
4.
KribbsNB, PackAI, KlineLR, SmithPL, SchwartzAR, SchubertNM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis1993;147(4):887–895.
5.
FletcherEC, LuckettRA. The effect of positive reinforcement on hourly compliance in nasal continuous positive airway pressure users with obstructive sleep apnea. Am Rev Respir Dis1991;143(5 Pt 1): 936–941.
6.
EdingerJD, RadtkeRA. Use of in vivo desensitization to treat a patient's claustrophobic response to nasal CPAP. Sleep1993;16(7): 678–680.
7.
GuilleminaultC.Clinical features and evaluation of obstructive sleep apnea. In: KrygerMH, RothT, DementWC, editors. Principles and practice of sleep medicine. Philadelphia: WB Saunders; 1994:667–677.
8.
YoungT, PaltaM, DempseyJ, SkatrudJ, WeberS, BadrS.The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med1993;328(17):1230–1235.
9.
HaponikEF, SmithPL, BohlmanME, AllenRP, GoldmanSM, BleeckerER. Computerized tomography in obstructive sleep apnea: correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis1983;127(2):221–226.
10.
SchwabRJ, GefterWB, HoffmanEA, GuptaKB, PackAI. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis1993;148(5):1385–1400.
11.
SchwabRJ, GuptaKB, GefterWB, MetzgerLJ, HoffmanEA, PackAI. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing: significance of the lateral pharyngeal walls. Am J Respir Crit Care Med1995;152(5 Pt 1):1673–1689.
12.
DaviesRJ, StradlingJR. The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. Eur Respir J1990;3(5):509–514.
13.
StrobelRJ, RosenRC. Obesity and weight loss in obstructive sleep apnea: a clinical review. Sleep1996;19(2):104–115.
14.
HoffsteinV, ZamelN, PhillipsonEA. Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis1984;130(2):175–178.
15.
MezzanotteWS, TangelDJ, WhiteDP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest1992;89(5): 1571–1579.
16.
HarmanEM, WynneJW, BlockAJ. The effect of weight loss on sleepdisordered breathing and oxygen desaturation in morbidly obese men. Chest1982;82(3):291–294.
17.
SmithPL, GoldAR, MeyersDA, HaponikEF, BleeckerER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med1985;103(6 Pt 1):850–855.
18.
BrowmanCP, SampsonMG, YollesSF, GujavartyKS, WeilerSJ, WalslebenJA, et al. Obstructive sleep apnea and body weight. Chest1984;85(3):435–438.
19.
PasqualiR, ColellaP, CirignottaF, MondiniS, GerardiR, BurattiP, et al. Treatment of obese patients with obstructive sleep apnea syndrome (OSAS): effect of weight loss and interference of otorhinolaryngoiatric pathology. Int J Obes1990;14(3):207–217.
20.
PeiserJ, LavieP, OvnatA, CharuziI.Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery. Ann Surg1984;199(1):112–115.
21.
SugermanHJ, FairmanRP, SoodRK, EngleK, WolfeL, KellumJM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr1992;55(2 Suppl):597S–601S.
22.
AbenhaimL, MorideY, BrenotF, RichS, BenichouJ, KurzX, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Group. N Engl J Med1996;335(9):609–616.
23.
ConnollyHM, CraryJL, McGoonMD, HensrudDD, EdwardsBS, EdwardsWD, SchaffHV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med1997;337(9):581–588.
24.
SheltonKE, WoodsonH, GayS, SurattPM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis1993;148(2):462–466.
25.
RubinsteinI, ColapintoN, RotsteinLE, BrownIG, HoffsteinV.Improvement in upper airway function after weight loss in patients with obstructive sleep apnea. Am Rev Respir Dis1988;138(5): 1192–1195.
26.
BraverHM, BlockAJ, PerriMG. Treatment for snoring: combined weight loss, sleeping on side, and nasal spray. Chest1995;107(5): 1283–1288.
27.
WingRR. Behavioral treatment of severe obesity. Am J Clin Nutr1992;55(2 Suppl):545S–551S.
28.
PhillipsBA, OkesonJ, PaesaniD, GilmoreR.Effect of sleep position on sleep apnea and parafunctional activity. Chest1986;90(3): 424–429.
29.
CartwrightRD. Effect of sleep position on sleep apnea severity. Sleep1984;7(2):110–114.
30.
GeorgeCF, MillarTW, KrygerMH. Sleep apnea and body position during sleep. Sleep1988;11(1):90–99.
31.
CartwrightRD, DiazF, LloydS.The effects of sleep posture and sleep stage on apnea frequency. Sleep1991;14(4):351–353.
32.
PevernagieDA, ShepardJWJr. Relations between sleep stage, posture and effective nasal CPAP levels in OSA. Sleep1992;15(2): 162–167.
33.
McEvoyRD, SharpDJ, ThorntonAT. The effects of posture on obstructive sleep apnea. Am Rev Respir Dis1986;133(4):662–666.
34.
FoukeJM, StrohlKP. Effect of position and lung volume on upper airway geometry. J Appl Physiol1987;63(1):375–380.
35.
YildirimN, FitzpatrickMF, WhyteKF, JallehR, WightmanAJA, DouglasNJ. The effect of posture on upper airway dimensions in normal subjects and in patients with the sleep apnea/hypopnea syndrome. Am Rev Respir Dis1991;144(4):845–847.
36.
PaeEK, LoweAA, SasakiK, PriceC, TsuchiyaM, FleethamJA. A cephalometric and electromyographic study of upper airway structures in the upright and supine positions. Am J Orthod Dentofacial Orthop1994;106(1):52–59.
37.
MartinSE, MarshallI, DouglasNJ. The effect of posture on airway caliber with the sleep-apnea/hypopnea syndrome. Am J Respir Crit Care Med1995;152(2):721–724.
38.
PevernagieDA, StansonAW, SheedyPF2nd, DanielsBK, ShepardJWJr. Effects of body position on the upper airway of patients with obstructive sleep apnea. Am J Respir Crit Care Med1995;152(1):179–185.
39.
BrownIB, McCleanPA, BoucherR, ZamelN, HoffsteinV.Changes in pharyngeal cross-sectional area with posture and application of continuous positive airway pressure in patients with obstructive sleep apnea. Am Rev Respir Dis1987;136(3):628–632.
40.
NeillAM, AngusSM, SajkovD, McEvoyRD. Effects of sleep posture on upper stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med1997;155(1):199–204.
41.
CartwrightRD, LloydS, LilieJ, KravitzH.Sleep position training as treatment for sleep apnea syndrome: a preliminary study. Sleep1985;8(2):87–94.
42.
CartwrightR, RistanovicR, DiazF, CaldarelliD, AlderG.A comparative study of treatments for positional sleep apnea. Sleep1991;14(6):546–552.
43.
ChaudharyBA, ChaudharyTK, KolbeckRC, HarmonJD, SpeirWAJr. Therapeutic effect of posture in sleep apnea. South Med J1986;79(9):1061–1063.
44.
TaasanVC, BlockAJ, BoysenPG, WynneJW. Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med1981;71(2):240–245.
45.
ScrimaL, BroudyM, NayKN, CohnMA. Increased severity of obstructive sleep apnea after bedtime alcohol ingestion: diagnostic potential and proposed mechanism of action. Sleep1982;5(4):318–328.
46.
KrolRC, KnuthSL, BartlettDJr. Selective reduction of genioglossal muscle activity by alcohol in normal human subjects. Am Rev Respir Dis1984;129(2):247–250.
47.
BonoraM, ShieldsGI, KnuthSL, BartlettDJr, St JohnWM. Selective depression by ethanol of upper airway respiratory activity in cats. Am Rev Respir Dis1984;130(2):156–161.
48.
RobinsonRW, WhiteDP, ZwillichCW. Moderate alcohol ingestion increases upper airway resistance in normal subjects. Am Rev Respir Dis1985;132(6):1238–1241.
49.
BlockAJ. Alcohol ingestion does not cause sleep-disordered breathing in premenopausal women. Alcohol Clin Exp Res1984;8(4): 397–398.
50.
BlockAJ, HellardDW, SlaytonPC. Minimal effect of alcohol ingestion on breathing during the sleep of postmenopausal women. Chest1985;88(2):181–184.
51.
LeiterJC, DobleEA, KnuthSL, BartlettDJr. Respiratory activity of genioglossus: interaction between alcohol and the menstrual cycle. Am Rev Respir Dis1987;135(2):383–386.
DollyFR, BlockAJ. Effect of flurazepam on sleep-disordered breathing and nocturnal desaturation in asymptomatic subjects. Am J Med1982;73(2):239–243.
54.
MendelsonWB, GarnettD, GillinJC. Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis1981;169(4):261–264.
55.
BonoraM, St JohnWM, BledsoeTA. Differential elevation by protriptyline and depression by diazepam of upper airway respiratory motor activity. Am Rev Respir Dis1985;131(1):41–45.
56.
LeiterJC, KnuthSL, KrolRC, BartlettDJr. The effect of diazepam on genioglossal muscle activity in normal human subjects. Am Rev Respir Dis1985;132(2):216–219.
57.
HedemarkLL, KronenbergRS. Flurazepam attenuates the arousal response to CO2 during sleep in normal subjects. Am Rev Respir Dis1983;128(6):980–983.
58.
BerryRB, KouchiK, BowerJ, ProsiseG, LightRW. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med1995;151(2 Pt 1):450–454.
59.
CamachoME, MorinCM. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep1995;18(8): 644–645.
60.
WetterDW, YoungTB, BidwellTR, BadrMS, PaltaM.Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med1994;154(19):2219–2224.
61.
NeillyJB, KribbsNB, MaislinG, PackAI. Effects of selective sleep deprivation on ventilation during recovery sleep in normal humans. J Appl Physiol1992;72(1):100–109.
62.
WhiteDP, DouglasNJ, PickettCK, ZwillichCW, WeilJV. Sleep deprivation and the control of ventilation. Am Rev Respir Dis1983; 128(6):984–986.
Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med1980;93(3):391–398.
65.
FletcherEC, MunafoDA. Role of nocturnal oxygen therapy in obstructive sleep apnea: when should it be used?Chest1990;98(6): 1497–1504.
66.
MartinRJ, SandersMH, GrayBA, PennockBE. Acute and long-term ventilatory effects of hyperoxia in the adult sleep apnea syndrome. Am Rev Respir Dis1982;125(2):175–180.
67.
AlfordNJ, FletcherEC, NickesonD.Acute oxygen in patients with sleep apnea and COPD. Chest1986;89(1):30–38.
68.
KimoffRJ, CheongTH, OlhaAE, CharbonneauM, LevyRD, CosioMG, GottfriedSB. Mechanisms of apnea termination in obstructive sleep apnea: role of chemoreceptor and mechanoreceptor stimuli. Am J Respir Crit Care Med1994;149(3 Pt 1):707–714.
69.
FletcherEC, SchaafJW, MillerJ, FletcherJG. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis1987;135(3):525–533.
70.
SmithPL, HaponikEF, BleeckerER. The effects of oxygen in patients with sleep apnea. Am Rev Respir Dis1984;130(6):958–963.
71.
PhillipsBA, SchmittFA, BerryDTR, LambDG, AminM, CookYR. Treatment of obstructive sleep apnea: a preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest1990; 98(2):325–330.
72.
AljadeffG, GozalD, Bailey-WahlSL, BurrellB, KeensTG, WardSL. Effects of overnight supplemental oxygen in obstructive sleep apnea in children. Am J Respir Crit Care Med1996;153(1):51–55.
73.
GoldAR, BleeckerER, SmithPL. A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. Am Rev Respir Dis1985;132(2):220–223.
74.
ChaunceyJB, AldrichMS. Preliminary findings in the treatment of obstructive sleep apnea with transtracheal oxygen. Sleep1990;13(2):167–174.
BrownellLG, WestP, SweatmanP, AcresJC, KrygerMH. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med1982;307(17):1037–1042.
77.
WhyteKF, GouldGA, AirlieMA, ShapiroCM, DouglasNJ. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep1988;11(5):463–472.
78.
ConwayWA, ZorickF, PiccioneP, RothT.Protriptyline in the treatment of sleep apnoea. Thorax1982;37(1):49–53.
79.
SmithPL, HaponikEF, BleeckerER. The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis1983;127(1):8–13.
80.
HanzelDA, ProiaNG, HudgelDW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest1991;100(2):416–421.
81.
LyonsHA, HuangCT. Therapeutic use of progesterone in alveolar hypoventilation associated with obesity. Am J Med1968;44(6): 881–888.
82.
SuttonFDJr, ZwillichCW, CreaghCE, PiersonDJ, WeilJV. Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med1975;83(4):476–479.
KimuraH, TatsumiK, KunitomoF, OkitaS, TojimaH, KouchiyamaS, et al. Progesterone therapy for sleep apnea syndrome evaluated by occlusion pressure responses to exogenous loading. Am Rev Respir Dis1989;139(5):1198–1206.
85.
OrrWC, ImesNK, MartinRJ. Progesterone therapy in obese patients with sleep apnea. Arch Intern Med1979;139(1):109–111.
86.
RajagopalKR, AbbrechtPH, JabbariB.Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest1986;90(6):815–821.
87.
CookWR, BenichJJ, WooterSA. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest1989;96(2):262–266.
88.
CollopNA. Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Chest1994;106(3):792–799.
89.
KriegerJ, ManginP, KurtzD.Effects of almitrine in the treatment of sleep apnea syndromes. Bull Eur Physiopathol Respir1983;19(6):630.
90.
EspinozaH, AnticR, ThorntonAT, McEvoyRD. The effects of aminophylline on sleep and sleep-disordered breathing with obstructive sleep apnea syndrome. Am Rev Respir Dis1987;136(1):80–84.
91.
SharpJT, DruzWS, D'SouzaV, DiamondE.Effect of metabolic acidosis upon sleep apnea. Chest1985;87(5):619–624.
92.
TojimaH, KunitomoF, KimuraH, TatsumiK, KuriyamaT, HondaY.Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax1988;43(2):113–119.
93.
StrolloPJ, EpsteinLJ, DermanS.Reversal of sleep disordered breathing with a continuous estrogen/progesterone regimen. In: ChaseM, KruegerJ, O'ConnorC, editors. Sleep research. Los Angeles: Brain Information Service/Brain Research Institute; 1993:22:280.
94.
CistulliPA, BarnesDJ, GrunsteinRR, SullivanCE. Effect of shortterm hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax1994;49(7):699–702.
95.
ArnulfI, HomeyerP, GarmaL, WhitelawWA, DerenneJP. Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration1997;64(2):159–161.
DavilaDG, HurtRD, GoffordKP, HarrisCD, ShepardJWJr. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med1994;150(2):469–474.
98.
OrrWC, MalesJL, ImesNK. Myxedema and obstructive sleep apnea. Am J Med1981;70(5):1061–1066.
99.
SandersMH. Medical therapy for sleep apnea. In: KrygerM, RothT, DementWC, editors. Principles and practice of sleep medicine, 2nd ed. Philadelphia: WB Saunders; 1994:678–693.
100.
RajagopalKR, AbbrechtPH, DerderianSS, PicketC, HofeldtF, TellisCJ, ZwillichCW. Obstructive sleep apnea in hypothyroidism. Ann Int Med1984;101(4):491–494.
101.
WinklemanJW, GoldmanH, PiscatelliN, LukasSE, DorseyCM, CunninghamS.Are thyroid function tests necessary in patients with suspected sleep apnea?Sleep1996;19(10):790–793.
102.
ChansonP, TimsitJ, BenoitO, AugendreB, MoulonguetM, GuillausseauPG, et al. Rapid improvement in sleep apnoea of acromegaly after short-term treatment with somatostatin analogue SMS 201-995 (letter). Lancet1986;1(8492):1270–1271.
103.
EpsteinLJ, StrolloPJJr, DoneganRB, DelmarJ, HendrixC, WestbrookPR. Obstructive sleep apnea in patients with human immunodeficiency virus (HIV) disease. Sleep1995;18(5):368–376.
104.
LoweAA. Dental appliances for the treatment of snoring and/or obstructive sleep apnea. In: KrygerM, RothT, DementW, editors. Principles and practice of sleep medicine, 2nd ed. Philadelphia: WB Saunders; 1994:722–735.
105.
Schmidt-NowaraW, LoweA, WiegandL, CartwrightR, Perez-GuerraF, MennS.Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep1995;18(6):501–510.
106.
BonhamPE, CurrierGF, OrrWC, OthmanJ, NandaRS. The effect of a modified functional appliance on obstructive sleep apnea. Am J Orthod Dentofacial Orthop1988;94(5):384–392.
107.
Schmidt-NowaraWW, MeadTE, HaysMB. Treatment of snoring and obstructive sleep apnea with a dental orthosis. Chest1991;99(6):1378–1385.
108.
LoweA, FleethamJ, RyanF, MathewsB.Effects of a mandibular repositioning appliance used in the treatment of obstructive sleep apnea on tongue muscle activity. In: IssaFB, SurattPM, RemmersJE, editors. Sleep and respiration. New York: Wiley-Liss; 1990:395–405.
109.
CartwrightRD, SamelsonCF. The effects of a nonsurgical treatment for obstructive sleep apnea: the tongue-retaining device. JAMA1982;248(6):705–709.
110.
FergusonKA, OnoT, LoweAA, KeenanSP, FleethamJA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest1996;109(5):1269–1275.
111.
ClarkGT, BlumenfeldI, YoffeN, PeledE, LavieP.A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest1996;109(6):1477–1483.
112.
American Sleep Disorders Association Report. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep1995;18(6):511–513.
113.
AfzeliusLE, ElmqvistD, HougaardK, LaurinS, NilssonB, RisbergAM. Sleep apnea syndrome an alternative treatment to tracheostomy. Laryngoscope1981;91(2):285–291.
114.
NahmiasJS, KaretzkyMS. Treatment of the obstructive sleep apnea syndrome using a nasopharyngeal tube. Chest1988;94(6):1142–1147.
115.
MikiH, HidaW, ChonanT, KikuchiY, TakishimaT.Effects of submental electrical stimulation during sleep on upper airway patency in patients with obstructive sleep apnea. Am Rev Respir Dis1989; 140(5):1285–1289.
EdmondsLC, DanielsBK, StansonAW, SheedyPF3rd, ShepardJWJr. The effects of transcutaneous electrical stimulation during wakefulness and sleep in patients with obstructive sleep apnea. Am Rev Respir Dis1992;146(4):1030–1036.
118.
GuilleminaultC, PowellN, BowmanB, StoohsR.The effect of electrical stimulation on obstructive sleep apnea syndrome. Chest1995;107(1):67–73.
119.
SchwartzAR, EiseleDW, HariA, TestermanR, EricksonD, SmithPL. Electrical stimulation of the lingual musculature in obstructive sleep apnea. J Appl Physiol1996;81(2):643–652.
120.
EiseleDW, SmithPL, AlamDS, SchwartzAR. Direct hypoglossal nerve stimulation in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg1997;123(1):57–61.
121.
PetrusonB.Snoring can be reduced when the nasal airflow is increased by the dilator Nozovent. Arch Otolaryngol Head Neck Surg1990;116(4):462–464.
122.
HoffsteinV, MateikaS, MetesA.Effect of nasal dilation on snoring and apneas during different stages of sleep. Sleep1993;16(4): 360–365.